Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
Most Cited Paper
in Retinal Development and Disorders
18 Months Post-Publication
Class of 2026
“Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
faricimab · Anti-VEGF therapy · neovascular AMD · diabetic macular edema · partial response · treatment switching · Visual acuity · ETDRS letters · central subfield thickness · treatment interval extension · treatment resistance · anatomical response · Real-world outcomes · Oxford Eye Hospital · retrospective study
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Retinal Development and Disorders Papers, Class of 2026. https://pri.pepkio.com/top-papers/retinal-development-and-disorders/2026. Accessed 2026-10-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459